Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 402.88 M391.77 M419.01 M440.5 M 1.65 B Research & development ———— — Operating income 139.68 M174.39 M144.32 M158.7 M 617.09 M Non-Operating Income, Total 6.18 M8.89 M8.13 M— — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 000— — Unusual income/expense 6.18 M8.89 M8.13 M— — Pretax income 145.87 M183.27 M152.44 M123.31 M 604.89 M Equity in earnings ———— — Taxes 30.16 M39.41 M36.01 M27.04 M 132.61 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 115.7 M143.87 M116.44 M96.27 M 472.28 M Discontinued operations ———— — Net income 115.7 M143.87 M116.44 M96.27 M 472.28 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 115.7 M143.87 M116.44 M96.27 M 472.28 M Basic earnings per share (Basic EPS) 1.321.61.31.07 5.29 Diluted earnings per share (Diluted EPS) 1.31.581.281.04 5.2 Average basic shares outstanding 87.5 M89.67 M89.71 M90.19 M — Diluted shares outstanding 88.8 M91.17 M91.29 M91.81 M — EBITDA ———— — EBIT 506.12 M534.15 M532.2 M564.89 M 2.14 B Cost of revenue 938.78 M938.59 M964.03 M1.2 B 4.04 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —